AIDS Alert Archives – September 1, 2009
September 1, 2009
View Issues
-
Recession, state budget cuts imperil drug assistance programs
States across the nation are starting waiting lists and cutting to the bone in their AIDS Drug Assistance Programs (ADAPs) due to an extraordinarily bad year for state budgets, ADAP directors say. -
Two hard-hit states maintain ADAP services
Not all states are facing a crisis with their AIDS Drug Assistance Programs (ADAPs) this year, despite the widespread economic downturn. -
Q&A HIV screening tool: New HIV combo assay identifies infection earlier than standard test
Peter Leone, MD, a professor of Medicine at the University of North Carolina in Chapel Hill and the medical director of the North Carolina HIV and STD Prevention and Care Program, has studied the ARCHITECT HIV Combo Assay, a new HIV test that identifies infection sooner than the standard antibody HIV test. -
HIV trials instructive to other researchers
Few diseases have anywhere near the clout, exposure, and clinical trial support of HIV/AIDS. Dedicated foundations, advocacy groups, and international organizations have spent more than two decades working to ensure HIV prevention and medication trials are a top priority for governments and private industry. -
FDA Notifications
On July 23, 2009, FDA granted approval for zidovudine 60 mg scored tablets for pediatric use, manufactured by Aurobindo Pharma Limited of Hyderabad, India. The application was reviewed under expedited review provisions for the President's Emergency Plan for AIDS Relief (PEPFAR).